Sumitomo Life Insurance’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-9,939	Closed	-$710K	–	260
2018 Q4	$710K	Buy	9,939 +180	+2%	+$12.9K	0.1%	231
2018 Q3	$1.2M	Buy	+9,759	New	+$1.2M	0.14%	214